Lactobacillus plantarum 299 clinical trials
How each study uses lactobacillus plantarum 299 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
3 studies that test it; most in 2012 (2)
| Year | Studies |
|---|---|
| 2012 | 2 |
| 2018 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 3
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses lactobacillus plantarum 299 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Lactobacillus Plantarum in Preventing Acute Graft Versus Host Disease in Children Undergoing Donor Stem Cell TransplantActive, not recruitingPhase 3Children's Oncology GroupNCT03057054Written as Lactobacillus plantarum strain 299How we know
- Probiotics Against Pathogenic Bacteria in Connection With AnaesthesiaCompletedNot applicableRegion SkaneNCT01521650Written as ProbioticsHow we know
- Probiotics for Reduction of Infections With Clostridium Difficile in Critically Ill PatientsTerminatedNot applicableRegion SkaneNCT01687543Written as L. plantarum 299 and L. plantarum 299v (+maltodextrin)How we know
Codes
What other systems call lactobacillus plantarum 299 · ClinicalTrials.gg INT015272
- UNII (FDA) 6H16YUE9W5LACTOBACILLUS PLANTARUM 299One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 6H16YUE9W5 | LACTOBACILLUS PLANTARUM 299 | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.